CNBC

Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings

11 2 月, 2026

One Min Read

10 Views

Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down.

原文: https://www.cnbc.com/2026/02/11/csl-shares-ceo-departure-weak-earnings.html

Last Update: 11 2 月, 2026

Written By

Other Articles

Previous

夜期高水77點先導智能上市百威等業績

Next

藥明生物發盈喜料去年多賺46%

Related Posts

Retail investors are running head first into this topsy-turvy market

1 Min Read

Third Point, D.E. Shaw obtain agreements with CoStar. How the activists can build value

1 Min Read

Top Wall Street analysts find these 3 stocks attractive in these challenging times

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept